Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lung Neoplasms 2Behavior 1

Interventions

Carboplatin 351pembrolizumab 323Pemetrexed 248Cisplatin 220Paclitaxel 148Nivolumab 138durvalumab 134osimertinib 112atezolizumab 110Docetaxel 110Specimen Handling 91Radiotherapy 87Drug Therapy 85Magnetic Resonance Spectroscopy 77Etoposide 77Radiosurgery 72Gemcitabine 71Ipilimumab 54130-nm albumin-bound paclitaxel 54Bevacizumab 52cemiplimab 47tislelizumab 45Blood Specimen Collection 40Cetuximab 35Taxes 34Platinum 33Injections 33Biopsy 33Standard of Care 31Immunoglobulin G 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Transportation × Thoracic × 1 year × Clear all
NCT06628167 2026-03-24

LCS II

Abramson Cancer Center at Penn Medicine

Phase NA Completed
252 enrolled 7 charts
Thoracic

Lung Neoplasms

NCT06207435 2025-09-02

LCS

Abramson Cancer Center at Penn Medicine

Phase NA Completed
242 enrolled 8 charts
Thoracic

Behavior, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡